IDH2 and central nervous system cancer: Most IDH mutant gliomas with TP53 mutations had at least one of the CNAs +7q, +8q, −9p, and −11p (Fig 3), and those CNAs overlapped with −1p/19q in tumors lacked TP53 mutations.